Heart rhythm breakthrough? new ablation method targets stubborn AF
NCT ID NCT07590661
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding extra ablation to standard treatment can help people with persistent atrial fibrillation (a type of irregular heartbeat). About 350 adults will be randomly assigned to receive either standard ablation or standard ablation plus isolation of the left atrial posterior wall. Researchers will track heart rhythm for 12 months to see which group has fewer recurrences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pulsed field ablation (PFA) procedure
What this could lead to
If successful, this could lead to a more effective ablation strategy for persistent atrial fibrillation, reducing recurrence of abnormal heart rhythms.
What could go wrong
This is an early-stage study (not yet recruiting) with 350 participants. The added procedure may not improve success rates and carries risks like bleeding or heart tissue damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Yunnan Hospital
Kunming, Yunnan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••